Literature DB >> 19892353

Low-carbohydrate diets reduce lipid accumulation and arterial inflammation in guinea pigs fed a high-cholesterol diet.

Jose O Leite1, Ryan DeOgburn, Joseph Ratliff, Randy Su, Joan A Smyth, Jeff S Volek, Mary M McGrane, Alan Dardik, Maria Luz Fernandez.   

Abstract

INTRODUCTION: Low-carbohydrate diets (LCD) efficiently induce weight loss and favorably affect plasma lipids, however, the effect of LCD on atherosclerosis is still argued.
OBJECTIVE: To evaluate the effect of LCD on the prevention of atherosclerosis.
METHODS: Twenty guinea pigs were fed either a LCD or a low-fat diet (LFD) in combination with high-cholesterol (0.25g/100g) for 12 weeks. The percentage energy of macronutrient distribution was 10:65:25 for carbohydrate:fat:protein for the LCD, and 55:20:25 for the LFD. Plasma lipids were measured using colorimetric assays. Plasma and aortic oxidized (oxLDL) were quantified using ELISA methods. Inflammatory cytokines were measured in aortic homogenates using an immunoassay. H&E stained sections of aortic sinus and Schultz stained sections of carotid arteries were examined.
RESULTS: LDL cholesterol was lower in the LCD compared to the LFD group (71.9+/-34.8 vs. 81.7+/-26.9mg/dL; p=0.039). Aortic cholesterol was also lower in the LCD (4.98+/-1.3mg/g) compared to the LFD group (6.68+/-2.0mg/g); p<0.05. The Schultz staining method confirmed less aortic cholesterol accumulation in the LCD group. Plasma oxLDL did not differ between groups, however, aortic oxLDL was 61% lower in the LCD compared to the LFD group (p=0.045). There was a positive correlation (r=0.63, p=0.03) between oxLDL and cholesterol concentration in the aorta of LFD group, which was not observed in LCD group (r=-0.05, p=0.96). Inflammatory markers were reduced in guinea pigs from the LCD group (p<0.05) and they were correlated with the decreases in oxLDL in aorta.
CONCLUSION: These results suggest that LCD not only decreases lipid deposition, but also prevents the accumulation of oxLDL and reduces inflammatory cytokines within the arterial wall and may prevent atherosclerosis. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892353     DOI: 10.1016/j.atherosclerosis.2009.10.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Effects of dietary cold-pressed turnip rapeseed oil and butter on serum lipids, oxidized LDL and arterial elasticity in men with metabolic syndrome.

Authors:  Ari Palomäki; Hanna Pohjantähti-Maaroos; Marja Wallenius; Päivi Kankkunen; Heikki Aro; Sari Husgafvel; Juha-Matti Pihlava; Kalevi Oksanen
Journal:  Lipids Health Dis       Date:  2010-12-01       Impact factor: 3.876

2.  Analysis of Carotid Ultrasound Screening of High-Risk Groups of Stroke Based on Big Data Technology.

Authors:  Jiankang Guo; Yanhong Bai; Minxia Ding; Lisha Song; Guo Yu; You Liang; Zhigang Fan
Journal:  J Healthc Eng       Date:  2022-01-25       Impact factor: 2.682

3.  Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation.

Authors:  Chi Zhang; Minglong Shao; Hong Yang; Liangmiao Chen; Lechu Yu; Weitao Cong; Haishan Tian; Fangfang Zhang; Peng Cheng; Litai Jin; Yi Tan; Xiaokun Li; Lu Cai; Xuemian Lu
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

4.  Advice to follow a low-carbohydrate diet has a favourable impact on low-grade inflammation in type 2 diabetes compared with advice to follow a low-fat diet.

Authors:  Lena Jonasson; Hans Guldbrand; Anna K Lundberg; Fredrik H Nystrom
Journal:  Ann Med       Date:  2014-04-30       Impact factor: 4.709

5.  Cholesterol-induced inflammation and macrophage accumulation in adipose tissue is reduced by a low carbohydrate diet in guinea pigs.

Authors:  David Aguilar; Ryan C deOgburn; Jeff S Volek; Maria Luz Fernandez
Journal:  Nutr Res Pract       Date:  2014-11-01       Impact factor: 1.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.